<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nmp</journal-id><journal-title-group><journal-title xml:lang="ru">Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Sklifosovsky Journal "Emergency Medical Care"</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2223-9022</issn><issn pub-type="epub">2541-8017</issn><publisher><publisher-name>“N.V. Sklifosovsky Research Institute for Emergency Medicine”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.23934/2223-9022-2025-14-2-371-378</article-id><article-id custom-type="elpub" pub-id-type="custom">nmp-2182</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРЕДВАРИТЕЛЬНОЕ СООБЩЕНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRELIMINARY REPORT</subject></subj-group></article-categories><title-group><article-title>Оценка использования инновационной питательной смеси Нутризет д в программе нутритивной поддержки у больных с острым респираторным дистресс-синдромом</article-title><trans-title-group xml:lang="en"><trans-title>Evaluation of the Use of the Innovative Nutritional Mixture Nutriset D in the Nutritional Support Program for Patients with Acute Respiratory Distress Syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8458-5605</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малюк</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Malyuk</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малюк Анатолий Иванович - кандидат медицинских наук, главный врач БУЗОО «ГКБ № 1 им. Кабанова А.Н.».</p><p>644112, Омск, ул. Перелета, д. 7</p></bio><bio xml:lang="en"><p>Anatoly I. Malyuk - Candidate of Medical Sciences, Chief Physician of the A.N. Kabanov City Clinical Hospital.</p><p>Pereleta Str. 7, Omsk, 644112</p></bio><email xlink:type="simple">maluk-gkb@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6503-096X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гирш</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Girsh</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гирш Андрей Оттович - профессор, доктор медицинских наук, профессор кафедры общей хирургии ФГБОУ ВО ОмГМУ МЗ РФ.</p><p>644099, Омск, ул. Ленина, д. 12</p></bio><bio xml:lang="en"><p>Andrey O. Girsh - Professor, Doctor of Medical Sciences, Professor of the Department of General Surgery, Omsk State Medical University.</p><p>Lenina Str. 12, Omsk, 644099</p></bio><email xlink:type="simple">agirsh@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0741-3337</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Степанов</surname><given-names>С. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Stepanov</surname><given-names>S. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Степанов Сергей Степанович - доктор медицинских наук, старший научный сотрудник кафедры гистологии, цитологии и эмбриологии ФГБОУ ВО ОмГМУ МЗ РФ.</p><p>644099, Омск, ул. Ленина, д. 12</p></bio><bio xml:lang="en"><p>Sergey S. Stepanov - Doctor of Medical Sciences, Senior Researcher, Department of Histology, Cytology and Embryology, Omsk State Medical University.</p><p>Lenina Str. 12, Omsk, 644099</p></bio><email xlink:type="simple">serg_stepanov@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">БУЗ Омской области «Городская клиническая больница № 1 им. Кабанова А.Н.»<country>Россия</country></aff><aff xml:lang="en">A.N. Kabanov City Clinical Hospital No. 1, Department of Histology, Cytology and Embryology<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБОУ ВО «Омский государственный медицинский университет» МЗ РФ<country>Россия</country></aff><aff xml:lang="en">Omsk State Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>06</day><month>09</month><year>2025</year></pub-date><volume>14</volume><issue>2</issue><fpage>371</fpage><lpage>378</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Малюк А.И., Гирш А.О., Степанов С.С., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Малюк А.И., Гирш А.О., Степанов С.С.</copyright-holder><copyright-holder xml:lang="en">Malyuk A.I., Girsh A.O., Stepanov S.S.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.jnmp.ru/jour/article/view/2182">https://www.jnmp.ru/jour/article/view/2182</self-uri><abstract><p>ЦЕЛЬ Оценка использования питательной смеси Нутризет Д в программе нутритивной поддержки у больных с острым респираторным дистресс-синдромом согласно результатам мониторинга показателей питательного статуса, газообмена, органных нарушений, углеводного обмена и критериев переносимости осуществляемого энтерального питания.</p><p>МАТЕРИАЛ И МЕТОДЫ В исследовании участвовали 10 больных с острым респираторным дистресс-синдромом. В ходе работы у этих больных определяли энергопотребление, содержание в плазме альбумина, глюкозы и абсолютного количества лимфоцитов, выраженность полиорганной недостаточности. На основе полученных данных существляли статистический анализ.</p><p>РЕЗУЛЬТАТЫ Выявлена положительная динамика энергопотребления, индекса оксигенации, содержания в плазме альбумина, абсолютного количества лимфоцитов, глюкозы, а также уменьшение полиорганной недостаточности.</p><p>ВЫВОДЫ 1. Применение смеси Нутризет Д у больных с острым респираторным дистресс-синдромом содействует уменьшению энергопотребления, возрастанию в крови содержания альбумина и абсолютного числа лимфоцитов. 2. Использование смеси Нутризет Д у больных с острым респираторным дистресс-синдромом способствует снижению выраженности недостаточности органов и нарушений газообмена. 3. Введение смеси Нутризет Д больным с острым респираторным дистресс-синдромом не вызывает вздутия живота и сброса введённой смеси по зонду, что свидетельствует о её комплиментарной переносимости, всасываемости и перевариваемости.</p></abstract><trans-abstract xml:lang="en"><p>AIM OF STUDY Evaluation of the use of the nutritional mixture Nutriset D in the nutritional support program for patients with acute respiratory distress syndrome according to the results of monitoring indicators of nutritional status, gas exchange, organ disorders, carbohydrate metabolism and criteria for tolerance of the enteral nutrition.</p><p>MATERIAL AND METHODS The study involved 10 patients with acute respiratory distress syndrome. Energy consumption, plasma albumin, glucose and absolute lymphocyte counts, and the severity of multiple organ failure were determined. Statistical analysis was performed.</p><p>RESULTS Positive dynamics of energy consumption, oxygenation index, plasma albumin content, absolute lymphocyte count, glucose, as well as a decrease in multiple organ failure were revealed.</p><p>CONCLUSION 1. The use of Nutriset D mixture in patients with acute respiratory distress syndrome contributed to a decrease in energy consumption, an increase in the blood albumin and the absolute number of lymphocytes. 2. The use of Nutriset D mixture in patients with acute respiratory distress syndrome contributed to a decrease in the severity of organ failure and gas exchange disorders. 3. Administration of Nutriset D mixture to patients with acute respiratory distress syndrome did not cause bloating or discharge of the administered mixture through the tube, which indicated its complementary tolerance, absorption and digestibility.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>нутритивная поддержка</kwd><kwd>метабиотический комплекс</kwd><kwd>β-глюканы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>nutritional support</kwd><kwd>metabiotic complex</kwd><kwd>β-glucans</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Исследование не имеет спонсорской поддержки</funding-statement></funding-group><funding-group xml:lang="en"><funding-statement>The study has no sponsorship</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Петриков С.С., Хубутия М.Ш., Попова Т.С. (ред.) Парентеральное и энтеральное питание: Национальное руководство. 2-е изд., доп. и перераб. Москва: ГЭОТАР-Медиа; 2023.</mixed-citation><mixed-citation xml:lang="en">Petrikov SS, Khubutiya MSh, Popova TS (eds.) Parenteral’noe i enteral’noe pitanie. 2nd ed., add. and rev. Moscow: GEOTAR-Media Publ.; 2023. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Общероссийская общественная организация «Федерация анестезиологов и реаниматологов». Метаболический мониторинг и нутритивная поддержка при проведении длительной искусственной вентиляции легких. Клинические рекомендации. Москва; 2021. URL: https://gkb05.ru/wp-content/uploads/2023/10/mr_np_na_ivl.pdf [Дата обращения 23 мая 2025 г.].</mixed-citation><mixed-citation xml:lang="en">Obshcherossiyskaya obshchestvennaya organizatsiya “Federatsiya anesteziologov i reanimatologov”. Metabolicheskiy monitoring i nutritivnaya podderzhka pri provedenii dlitel’noy iskusstvennoy ventilyatsii legkikh. Klinicheskie rekomendatsii. Moscow; 2021. (In Russ.) Available at: https://gkb05.ru/wp-content/uploads/2023/10/mr_np_na_ivl.pdf [Accessed May 23, 2025].</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Chapman MJ, Nguyen NQ, Deane AM. Gastrointestinal dysmotility: Evidence and clinical management. Curr Opin Clin Nutr Metab Care. 2013;16(2):209–216. PMID: 23334174 https://doi.org/10.1097/MCO.0b013e32835c1fa5</mixed-citation><mixed-citation xml:lang="en">Chapman MJ, Nguyen NQ, Deane AM. Gastrointestinal dysmotility: Evidence and clinical management. Curr Opin Clin Nutr Metab Care. 2013;16(2):209–216. PMID: 23334174 https://doi.org/10.1097/MCO.0b013e32835c1fa5</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chapman MJ, Fraser RJ, Matthews G, Russo A, Bellon M, Besanko LK, et al. Glucose absorption and gastric emptying in critical illness. Crit Care. 2009;13(4):R140. PMID:19712450 https://doi.org/10.1186/cc8021</mixed-citation><mixed-citation xml:lang="en">Chapman MJ, Fraser RJ, Matthews G, Russo A, Bellon M, Besanko LK, et al. Glucose absorption and gastric emptying in critical illness. Crit Care. 2009;13(4):R140. PMID:19712450 https://doi.org/10.1186/cc8021</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Гельфанд Б.Р. (ред.) Сепсис: классификация, клинико-диагностическая концепция и лечение: практическое руководство. 4-е изд., доп. и перераб. Москва: Медицинское информационное агентство; 2017.</mixed-citation><mixed-citation xml:lang="en">Gel’fand BR (ed.). Sepsis: klassifikatsiya, kliniko-diagnosticheskaya kontseptsiya i lechenie. 4th ed., add. and rev. Moscow: Meditsinskoe informatsionnoe agentstvo Publ.; 2017. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Мазурок В.А., Головкин А.С., Баутин А.Е., Горелов И.И., Беликов В. Л., Сливин О.А. Желудочно-кишечный тракт при критических состояниях: первый страдает, последний, кому уделяют внимание. Вестник интенсивной терапии. 2016;(2):28–37.</mixed-citation><mixed-citation xml:lang="en">Mazurok VA, Golovkin AS, Bautin AE, Gorelov II, Belikov VL, Slivin ОА. Gastrointestinal Tract in Clinical Illness: the First Who Suffers, and the Last Who Recieves the Attention. Annals of Critical Care. 2016;(2):28–37. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Shenderov BA, Sinitsa AV, Zakharchenko MM, Lang C. Metabiotics. Present state, challenges and perspectives. Springer Cham; 2020.</mixed-citation><mixed-citation xml:lang="en">Shenderov BA, Sinitsa AV, Zakharchenko MM, Lang C. Metabiotics. Present state, challenges and perspectives. Springer Cham; 2020.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Боровиков В.П. Популярное введение в современный анализ данных в системе STATISTICA. Методология и технология современного анализа данных. Москва: Горячая линия – Телеком, 2013.</mixed-citation><mixed-citation xml:lang="en">Borovikov VP. Populyarnoe vvedenie v sovremennyy analiz dannykh v sisteme STATISTICA. Metodologiya i tekhnologiya sovremennogo analiza dannykh. Moscow: Goryachaya liniya – Telekom Publ., 2013 (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Desaka N, Ota C, Nishikawa H, Yasuda K, Ishii N, Bito T, et al. Streptococcus thermophilus prolongs lifespan by activating the DAF-16-mediated antioxidant pathway in Caenorhabditis elegans. J Clin Biochem Nutr. 2022;70(1):7–13. PMID: 35068675 https://doi.org/10.3164/jcbn.21–56</mixed-citation><mixed-citation xml:lang="en">Desaka N, Ota C, Nishikawa H, Yasuda K, Ishii N, Bito T, et al. Streptococcus thermophilus prolongs lifespan by activating the DAF-16-mediated antioxidant pathway in Caenorhabditis elegans. J Clin Biochem Nutr. 2022;70(1):7–13. PMID: 35068675 https://doi.org/10.3164/jcbn.21–56</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Herviou P, Balvay A, Bellet D, Bobet S, Maudet C, Staub J, et al. Transfer of the Integrative and Conjugative Element ICESt3 of Streptococcus thermophilus in Physiological Conditions Mimicking the Human Digestive Ecosystem. Microbiol Spectr. 2023;11(3):e0466722. PMID:36995244 https://doi.org/10.1128/spectrum.04667-22</mixed-citation><mixed-citation xml:lang="en">Herviou P, Balvay A, Bellet D, Bobet S, Maudet C, Staub J, et al. Transfer of the Integrative and Conjugative Element ICESt3 of Streptococcus thermophilus in Physiological Conditions Mimicking the Human Digestive Ecosystem. Microbiol Spectr. 2023;11(3):e0466722. PMID:36995244 https://doi.org/10.1128/spectrum.04667-22</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Salini F, Iacumin L, Comi G, Dicks LMT. Thermophilin 13: In Silico Analysis Provides New Insight in Genes Involved in Bacteriocin Production. Microorganisms. 2023;11(3):611–618. PMID: 36985185 https://doi.org/10.3390/microorganisms11030611</mixed-citation><mixed-citation xml:lang="en">Salini F, Iacumin L, Comi G, Dicks LMT. Thermophilin 13: In Silico Analysis Provides New Insight in Genes Involved in Bacteriocin Production. Microorganisms. 2023;11(3):611–618. PMID: 36985185 https://doi.org/10.3390/microorganisms11030611</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Roux E, Nicolas A, Valence F, Siekaniec G, Chuat V, Nicolas J, et al. The genomic basis of the Streptococcus thermophilus health-promoting properties. BMC Genomics. 2022;23(1):210. PMID: 35291951 https://doi.org/10.1186/s12864-022-08459-y</mixed-citation><mixed-citation xml:lang="en">Roux E, Nicolas A, Valence F, Siekaniec G, Chuat V, Nicolas J, et al. The genomic basis of the Streptococcus thermophilus health-promoting properties. BMC Genomics. 2022;23(1):210. PMID: 35291951 https://doi.org/10.1186/s12864-022-08459-y</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kang X, Liang H, Luo Y, Li Z, He F, Han X, et al. Biol Streptococcus thermophilus MN-ZLW-002 Can Inhibit Pre-adipocyte Differentiation through Macrophage Activation. Pharm Bull. 2021;44(3):316–324. PMID:33390424 https://doi.org/10.1248/bpb.b20-00335</mixed-citation><mixed-citation xml:lang="en">Kang X, Liang H, Luo Y, Li Z, He F, Han X, et al. Biol Streptococcus thermophilus MN-ZLW-002 Can Inhibit Pre-adipocyte Differentiation through Macrophage Activation. Pharm Bull. 2021;44(3):316–324. PMID:33390424 https://doi.org/10.1248/bpb.b20-00335</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Muderspach SJ, Fredslund F, Volf V, Poulsen JN, Blicher TH, Clausen MH, et al. Engineering the substrate binding site of the hyperthermostable archaeal endo-β-1,4-galactanase from Ignisphaera aggregans. Biotechnol Biofuels. 2021 Sep 16;14(1):183. PMID: 34530892 https://doi.org/10.1186/s13068-021-02025-6</mixed-citation><mixed-citation xml:lang="en">Muderspach SJ, Fredslund F, Volf V, Poulsen JN, Blicher TH, Clausen MH, et al. Engineering the substrate binding site of the hyperthermostable archaeal endo-β-1,4-galactanase from Ignisphaera aggregans. Biotechnol Biofuels. 2021 Sep 16;14(1):183. PMID: 34530892 https://doi.org/10.1186/s13068-021-02025-6</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Roy D. Probiotics. In: Moo-Young M (eds). Comprehensive Biotechnology. 3rd ed. Pergamon; 2019.</mixed-citation><mixed-citation xml:lang="en">Roy D. Probiotics. In: Moo-Young M (eds). Comprehensive Biotechnology. 3rd ed. Pergamon; 2019.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Козин С.В., Кравцов А.А., Кравченко С.В., Иващенко Л.И. Антиокси-дантный и анксиолитический эффекты Bifidobacterium adolescentis и Lactobacillus acidophilus в условиях нормобарической гипоксии с гиперкапнией. Вопросы питания. 2021;90(2):63–72. https://doi.org/10.33029/0042-8833-2021-90-2-63-72</mixed-citation><mixed-citation xml:lang="en">Kozin SV, Kravtsov AA, Kravchenko SV, Ivashchenko LI. Antioxidant and anxiolytic effect of Bifidobacterium adolescentis and Lactobacillus acidophilus under conditions of normobaric hypoxia with hypercapnia. Problems of Nutrition. 2021;90(2):63–72. (In Russ.) https://doi.org/10.33029/0042-8833-2021-90-2-63-72</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Derrien M, Turroni F, Ventura M, van Sinderen D. Insights into endogenous Bifidobacterium species in the human gut microbiota during adulthood. Trends Microbiol. 2022;30(10):940–947. PMID:35577716 https://doi.org/10.1016/j.tim.2022.04.004</mixed-citation><mixed-citation xml:lang="en">Derrien M, Turroni F, Ventura M, van Sinderen D. Insights into endogenous Bifidobacterium species in the human gut microbiota during adulthood. Trends Microbiol. 2022;30(10):940–947. PMID:35577716 https://doi.org/10.1016/j.tim.2022.04.004</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, Sánchez B, Margolles A. Bifidobacteria and Their Health-Promoting Effects. Microbiol Spectr. 2017;5(3):756–768. PMID: 28643627 https://doi.org/10.1128/microbiolspec.bad-0010-2016</mixed-citation><mixed-citation xml:lang="en">Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, Sánchez B, Margolles A. Bifidobacteria and Their Health-Promoting Effects. Microbiol Spectr. 2017;5(3):756–768. PMID:28643627 https://doi.org/10.1128/microbiolspec.bad-0010-2016</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Anjum FM, Saeed F, Afzaal M, Ikram A, Azam M The effect of thermal processing on probiotics stability. In: Advances in Dairy Microbial Products. Woodhead Publishing; 2022. Chapt. 20.pp. 295–302. https://doi.org/10.1016/B978-0-323-85793-2.00004-7</mixed-citation><mixed-citation xml:lang="en">Anjum FM, Saeed F, Afzaal M, Ikram A, Azam M The effect of thermal processing on probiotics stability. In: Advances in Dairy Microbial Products. Woodhead Publishing; 2022. Chapt. 20.pp. 295–302. https://doi.org/10.1016/B978-0-323-85793-2.00004-7</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Uusitupa HM, Rasinkangas P, Lehtinen MJ, Mäkelä SM, Airaksinen K, Anglenius H, et al. Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research. Nutrients. 2020;12(4):892. PMID: 32218248 https://doi.org/10.3390/nu12040892</mixed-citation><mixed-citation xml:lang="en">Uusitupa HM, Rasinkangas P, Lehtinen MJ, Mäkelä SM, Airaksinen K, Anglenius H, et al. Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research. Nutrients. 2020;12(4):892. PMID: 32218248 https://doi.org/10.3390/nu12040892</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bonfrate L, Di Palo DM, Celano G, Albert A, Vitellio P, De Angelis M, et al. Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients. Eur J Clin Invest. 2020;50(3):e13201. PMID: 31960952 https://doi.org/10.1111/eci.13201</mixed-citation><mixed-citation xml:lang="en">Bonfrate L, Di Palo DM, Celano G, Albert A, Vitellio P, De Angelis M, et al. Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients. Eur J Clin Invest. 2020;50(3):e13201. PMID: 31960952 https://doi.org/10.1111/eci.13201</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Caviglia GP, Tucci A, Pellicano R, Fagoonee S, Rosso C, Abate ML, et al. Clinical response and changes of cytokines and zonulin levels in patients with diarrhoea-predominant irritable bowel syndrome treated with bifidobacterium longum ES1 for 8 or 12 weeks: a preliminary report. J Clin Med. 2020;9(8):235323–59. PMID: 32717980 https://doi.org/10.3390/jcm9082353</mixed-citation><mixed-citation xml:lang="en">Caviglia GP, Tucci A, Pellicano R, Fagoonee S, Rosso C, Abate ML, et al. Clinical response and changes of cytokines and zonulin levels in patients with diarrhoea-predominant irritable bowel syndrome treated with bifidobacterium longum ES1 for 8 or 12 weeks: a preliminary report. J Clin Med. 2020;9(8):235323–59. PMID: 32717980 https://doi.org/10.3390/jcm9082353</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Yang J, Yang H. Antibacterial Activity of Bifidobacterium breve Against Clostridioides difficile. Front Cell Infect Microbiol. 2019;9:288. PMID: 31440478 https://doi.org/10.3389/fcimb.2019.00288 eCollection 2019.</mixed-citation><mixed-citation xml:lang="en">Yang J, Yang H. Antibacterial Activity of Bifidobacterium breve Against Clostridioides difficile. Front Cell Infect Microbiol. 2019;9:288. PMID: 31440478 https://doi.org/10.3389/fcimb.2019.00288 eCollection 2019.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Захарова Ю.В., Леванова Л.А. Современные представления о таксономии, морфологических и функциональных свойствах бифидо-бактерий. Фундаментальная и клиническая медицина. 2018;3(10):90–101. https://doi.org/10.23946/2500-0764-2018-3-1-90-101</mixed-citation><mixed-citation xml:lang="en">Zakharova YuV, Levanova LA. Current Opinion on Taxonomy, Morphological, and Functional Properties of Bifidobacteria. Fundamental and Clinical Medicine. 2018;3(1):90–101. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Бухарин О.В., Иванова Е.В., Чайникова И.Н., Перунова Н.Б., Никифоров И.А., Челпаченко О.Е. и др. Влияние кишечных микросим-бионтов на продукцию цитокинов в системе in vitro. Медицинская иммунология. 2023;25(6):1371–1388. https://doi.org/10.15789/1563-0625-IVE-2622</mixed-citation><mixed-citation xml:lang="en">Bukharin OV, Ivanova EV, Chaynikova IN, Perunova NB, Nikiforov IA, Chelpachenko OE, et al. In vitro effects of intestinal microsymbionts on the cytokine production. Medical Immunology (Russia). 2023;25(6):1371–1388. (In Russ.) https://doi.org/10.15789/1563-0625-IVE-2622</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Buchta Rosean C, Feng TY, Azar FN, Rutkowski MR. Impact of the microbiome on cancer progression and response to anti-cancer therapies. Adv Cancer Res. 2019;143:255–294. PMID: 31202360 https://doi.org/10.1016/bs.acr.2019.03.005</mixed-citation><mixed-citation xml:lang="en">Buchta Rosean C, Feng TY, Azar FN, Rutkowski MR. Impact of the microbiome on cancer progression and response to anti-cancer therapies. Adv Cancer Res. 2019;143:255–294. PMID: 31202360 https://doi.org/10.1016/bs.acr.2019.03.005</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Fidanza M, Panigrahi P, Kollmann TR. Lactiplantibacillus plantarum-Nomad and Ideal Probiotic. Front Microbiol. 2021;12:7136. PMID: 34690957 https://doi.org/10.3389/fmicb.2021.712236 eCollection 2021.</mixed-citation><mixed-citation xml:lang="en">Fidanza M, Panigrahi P, Kollmann TR. Lactiplantibacillus plantarum-Nomad and Ideal Probiotic. Front Microbiol. 2021;12:7136. PMID: 34690957 https://doi.org/10.3389/fmicb.2021.712236 eCollection 2021.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">El Kafsi H, Binesse J, Loux V, Buratti J, Boudebbouze S, Dervyn R, еt al. Lactobacillus delbrueckii ssp. lactis and ssp. bulgaricus: a chronicle of evolution in action. BMC Genomics. 2014;15(1):407. PMID: 24884896 https://doi.org/10.1186/1471-2164-15-407</mixed-citation><mixed-citation xml:lang="en">El Kafsi H, Binesse J, Loux V, Buratti J, Boudebbouze S, Dervyn R, еt al. Lactobacillus delbrueckii ssp. lactis and ssp. bulgaricus: a chronicle of evolution in action. BMC Genomics. 2014;15(1):407. PMID: 24884896 https://doi.org/10.1186/1471-2164-15-407</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Poh CL, Khalid K, Lim Y. Probiotics: A solution to the prevention of antimicrobial resistance. In: Dhara AK, Nayak AK, Chattopadhyay D, eds. Antibiotics – Therapeutic Spectrum and Limitations. Academic Press; 2023. Chapt. 23. pp.595–609. https://doi.org/10.1016/B978-0-323-95388-7.00017-6</mixed-citation><mixed-citation xml:lang="en">Poh CL, Khalid K, Lim Y. Probiotics: A solution to the prevention of antimicrobial resistance. In: Dhara AK, Nayak AK, Chattopadhyay D, eds. Antibiotics – Therapeutic Spectrum and Limitations. Academic Press; 2023. Chapt. 23. pp.595–609. https://doi.org/10.1016/B978-0-323-95388-7.00017-6</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Griffiths MW, Tellez AM. Lactobacillus helveticus: the proteolytic system. Front Microbiol. 2013;4:30. PMID: 23467265 https://doi.org/10.3389/fmicb.2013.00030 eCollection 2013.</mixed-citation><mixed-citation xml:lang="en">Griffiths MW, Tellez AM. Lactobacillus helveticus: the proteolytic system. Front Microbiol. 2013;4:30. PMID: 23467265 https://doi.org/10.3389/fmicb.2013.00030 eCollection 2013.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Taverniti V, Guglielmetti S. Health-promoting properties of Lactobacillus helveticus. Front Microbio. 2012;3:392. PMID: 23181058 https://doi.org/10.3389/fmicb.2012.00392 eCollection 2012.</mixed-citation><mixed-citation xml:lang="en">Taverniti V, Guglielmetti S. Health-promoting properties of Lactobacillus helveticus. Front Microbio. 2012;3:392. PMID: 23181058 https://doi.org/10.3389/fmicb.2012.00392 eCollection 2012.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Nora H, Ali A, Chaymae B, Haytham B, Mouncif M, Douaae O-Y, et al. Probiotic properties and antibiotic susceptibility assessment of Streptococcus thermophilus isolates. Research Square; 2023. Available at: https://www.researchsquare.com/article/rs-2917183/v1 [Accessed May 26, 2025]</mixed-citation><mixed-citation xml:lang="en">Nora H, Ali A, Chaymae B, Haytham B, Mouncif M, Douaae O-Y, et al. Probiotic properties and antibiotic susceptibility assessment of Streptococcus thermophilus isolates. Research Square; 2023. Available at: https://www.researchsquare.com/article/rs-2917183/v1 [Accessed May 26, 2025]</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Xu M, Ling F, Li J, Chen Y, Li S, Cheng Y, et al. Oat beta-glucan reduces colitis by promoting autophagy flux in intestinal epithelial cells via EPHB6-TFEB axis. Front Pharmacol. 2023;14:1189229. PMID: 37441529 https://doi.org/10.3389/fphar.2023.1189229 eCollection 2023.</mixed-citation><mixed-citation xml:lang="en">Xu M, Ling F, Li J, Chen Y, Li S, Cheng Y, et al. Oat beta-glucan reduces colitis by promoting autophagy flux in intestinal epithelial cells via EPHB6-TFEB axis. Front Pharmacol. 2023;14:1189229. PMID: 37441529 https://doi.org/10.3389/fphar.2023.1189229 eCollection 2023.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Spagnuolo R, Cosco C, Mancina RM, Ruggiero G, Garieri P, Cosco V, et al. Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowelsyndrome. Eur Rev Med Pharmacol Sci. 2017;21(2 Suppl):102–107. PMID: 28724171</mixed-citation><mixed-citation xml:lang="en">Spagnuolo R, Cosco C, Mancina RM, Ruggiero G, Garieri P, Cosco V, et al. Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2017;21(2 Suppl):102–107. PMID: 28724171</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Singh RP, Bhardwaj A. β-glucans: a potential source for maintaining gut microbiota and the immune system. Front Nutr. 2023;10:1143682. PMID: 37215217 https://doi.org/10.3389/fnut.2023.1143682 eCollection 2023.</mixed-citation><mixed-citation xml:lang="en">Singh RP, Bhardwaj A. β-glucans: a potential source for maintaining gut microbiota and the immune system. Front Nutr. 2023;10:1143682. PMID: 37215217 https://doi.org/10.3389/fnut.2023.1143682 eCollection 2023.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front Immunol. 2021;12:578386. PMID: 33717063 https://doi.org/10.3389/fimmu.2021.578386 eCollection 2021.</mixed-citation><mixed-citation xml:lang="en">Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front Immunol. 2021;12:578386. PMID: 33717063 https://doi.org/10.3389/fimmu.2021.578386 eCollection 2021.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y, Wang J, Wu C. Modulation of gut microbiota and immune system by probiotics, pre-biotics, and post-biotics. Front Nutr. 2022;8:634897. PMID: 35047537 https://doi.org/10.3389/fnut.2021.634897 eCollection 2021.</mixed-citation><mixed-citation xml:lang="en">Liu Y, Wang J, Wu C. Modulation of gut microbiota and immune system by probiotics, pre-biotics, and post-biotics. Front Nutr. 2022;8:634897. PMID: 35047537 https://doi.org/10.3389/fnut.2021.634897 eCollection 2021.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Zou Y, Liao D, Huang H, Li T, Chi H. A systematic review and meta-analysis of beta-glucan consumption on glycemic control in hypercholesterolemic individuals. Int J Food Sci Nutr. 2015;66(4):355–362. PMID: 26001090 https://doi.org/10.3109/09637486.2015.1034250</mixed-citation><mixed-citation xml:lang="en">Zou Y, Liao D, Huang H, Li T, Chi H. A systematic review and meta-analysis of beta-glucan consumption on glycemic control in hypercholesterolemic individuals. Int J Food Sci Nutr. 2015;66(4):355–362. PMID: 26001090 https://doi.org/10.3109/09637486.2015.1034250</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
